Return to study ST001251 main page

MB Sample ID: SA091103

Local Sample ID:17_23 _t_minus_50
Subject ID:SU001319
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Age Or Age Range:19-27
Weight Or Weight Range:58-92
Height Or Height Range:172-190
Gender:Male
Human Race:Caucasian
Human Trial Type:Prospective randomized open label controlled intervention study
Human Medications:None
Human Prescription Otc:None
Human Smoking Status:Non smoker
Human Alcohol Drug Use:Not in
Human Nutrition:Fasted for 12 hours before the first sample was obtained.
Human Inclusion Criteria:Healthy (normal physical examination, electrocardiography, and routine laboratory values).
Human Exclusion Criteria:Febrile illness during the 2 weeks before the endotoxemia experiment, taking any prescription medication, history of spontaneous vagal collapse, practicing or experience with any kind of meditation, or participation in a previous trial where LPS was administered.

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN002077
Analysis type MS
Chromatography type Reversed phase
Chromatography system Agilent 1290
Column Discovery HS F5-3 (15cm x 2.1 mm,3um) Supelco,Sigma Aldrich)
MS Type ESI
MS instrument type QTOF
MS instrument name Agilent 6540 QTOF
Ion Mode UNSPECIFIED
Units relative abundance

Chromatography:

Chromatography ID:CH001514
Instrument Name:Agilent 1290
Column Name:Discovery HS F5-3 (15cm x 2.1 mm,3um) Supelco,Sigma Aldrich)
Flow Gradient:5% B from 0-0.1min to 35% B at 1.5 min, to 95% B at 2.05 min which was kept constant until 3.2 min, to 5% B at 3.21 min and washing until 4.3 min with 5% B.
Flow Rate:The flow rate was kept constant at 700 µL/min from 0 min to 2.2 min, and increased up to 900 µL/min from 2.2 min to 2.5 min, after which flow rate was kept constant until 3.2 min.The flow rate was decreased from 900 µL/min to 800 µL/min from 3.2 min to 3.1 min and kept constant until 3.7 min, when flow rate was changed to 700 µL/min.
Injection Temperature:40 °C
Solvent A:95% water/5% acetonitrile; 0.1% formic acid; 10 mM ammonium formate
Solvent B:95% acetonitrile/5% water; 0.1% formic acid; 10 mM ammonium formate
Chromatography Type:Reversed phase
  logo